• Menu
  • Skip to right header navigation
  • Skip to main content

Before Header

Link Medical Research

CRO – Contract Research Organization

  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • Testimonials
  • Search
  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • Testimonials
  • Search

Top Content

Home / Collaborations for decentralised pilot study

Top Content 2

Collaborations for decentralised pilot study

We are thrilled to be working with AlzeCure Pharma on their pilot study with Painless ACD440 in peripheral neuropathic pain, where we will implement a new digital element for decentralized activities. This will create a smooth and flexible process for patient recruitment and will help with the pre-screening, eConsent, and remote visits via Viedoc Me while feeding in information to the eCRF.

In this picture, our team collaborates with Viedoc and the participating clinic to create a short information film for the patients. The video will be available through Viedoc during the eConsent process at the beginning of the study.

AlzeCure® is a Swedish pharmaceutical company that develops new innovative small molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer’s disease and pain – indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.

 

A strategic partnership with LINK Medical offers the expertise and guidance you need to accelerate your
time to market. 

Contact us to learn how we can help you with your product development using the most efficient tools and the best teams in the industry.












     

    Previous Post: «CRO – Contract Research Organization Clinical Research Associate
    Next Post: Customer praises our team »

    Site Footer

    Don't miss out on the latest updates

    Be the first to hear our breaking news at LINK Medical

    • Home
    • Solutions
    • Therapeutic areas
    • About Us
    • News & Events
    • Contact
    • Careers
    • Search

    © 2022 Link Medical Research
    Privacy Policy